title: Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer.
abstract: The impact of glycemic control in patients with pancreatic cancer treated with neoadjuvant therapy is unclear.
  
  
  
  Glycated hemoglobin (HbA1c) values were measured in patients with localized pancreatic cancer prior to any therapy (pretreatment) and after neoadjuvant therapy prior to surgery (preoperative). HbA1c levels greater than 6.5% were classified as abnormal. Patients were categorized based on the change in HbA1c levels from pretreatment to preoperative: GrpA, always normal; Gr B, worsened; GrpC, improved; and GrpD, always abnormal.
  
  
  
  Pretreatment HbA1c levels were evaluable in 123 patients; there were 67 (55%) patients in GrpA, 8 (6%) in GrpB, 22 (18%) in GrpC, and 26 (21%) in GrpD. Of the 123 patients, 92 (75%) completed all intended therapy to include surgery; 57 (85%) patients in GrpA, 4 (50%) patients in GrpB, 16 (72%) patients in GrpC, and 15 (58%) patients in GrpD (p = 0.01). Elevated preoperative carbohydrate antigen 19-9 (CA19-9) (OR 0.22;[0.07-0.66]), borderline resectable (BLR) disease stage (OR 0.20;[0.01-0.45]) and abnormal preoperative HbA1c (OR 0.30;[0.11-0.90]) were negatively associated with completion of all intended therapy. Abnormal preoperative HbA1c was associated with a 2.74-fold increased odds of metastatic progression during neoadjuvant therapy (p = 0.08).
  
  
  
  Elevated preoperative HbA1c is associated with failure to complete neoadjuvant therapy and surgery and a trend for increased risk of metastatic progression.
authors.affiliation: Department of Surgery (Division of Surgical Oncology), Pancreatic Cancer Program, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53226, USA.
authors.forename: E S Paul
authors.initials: ES
authors.lastname: Rajamanickam
authors.affiliation: Department of Surgery (Division of Surgical Oncology), Pancreatic Cancer Program, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53226, USA.
authors.forename: K K
authors.initials: KK
authors.lastname: Christians
authors.affiliation: Department of Surgery (Division of Surgical Oncology), Pancreatic Cancer Program, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53226, USA.
authors.forename: M
authors.initials: M
authors.lastname: Aldakkak
authors.affiliation: Department of Surgery (Division of Surgical Oncology), Pancreatic Cancer Program, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53226, USA.
authors.forename: A N
authors.initials: AN
authors.lastname: Krepline
authors.affiliation: Department of Medicine, Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: P S
authors.initials: PS
authors.lastname: Ritch
authors.affiliation: Department of Medicine, Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: B
authors.initials: B
authors.lastname: George
authors.affiliation: Department of Radiation Oncology, Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: B A
authors.initials: BA
authors.lastname: Erickson
authors.affiliation: Department of Radiology, Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: W D
authors.initials: WD
authors.lastname: Foley
authors.affiliation: Department of Gastroenterology, Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: M
authors.initials: M
authors.lastname: Aburajab
authors.affiliation: Department of Surgery (Division of Surgical Oncology), Pancreatic Cancer Program, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53226, USA.
authors.forename: D B
authors.initials: DB
authors.lastname: Evans
authors.affiliation: Department of Surgery (Division of Surgical Oncology), Pancreatic Cancer Program, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53226, USA. stsai@mcw.edu.
authors.forename: S
authors.initials: S
authors.lastname: Tsai
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018395:CA-19-9 Antigen / Q000097:blood; D059186:Chemoradiotherapy, Adjuvant; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009362:Neoplasm Metastasis; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D018395:CA-19-9 Antigen; D006442:Glycated Hemoglobin
keywords: Diabetes; Neoadjuvant therapy; Pancreatic cancer